Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) consisting of persistent and relapsing inflammatory processes of the intestinal mucosa are caused by genetic, environmental, and commensal microbiota factors. Despite recent advances in clinical treatments aiming to decrease inflammation, nearly 30% of patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Santalla, Mercedes, Garin, Marina Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615066/
https://www.ncbi.nlm.nih.gov/pubmed/34829736
http://dx.doi.org/10.3390/biomedicines9111507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615066/
https://www.ncbi.nlm.nih.gov/pubmed/34829736
http://dx.doi.org/10.3390/biomedicines9111507

Ejemplares similares